The study was proposed to evaluate co-morbid depression, anxiety and stress associated with tinnitus patients. The study was done on 196 subjects: 100 patients suffering from subjective tinnitus associated with hearing loss (tinnitus group), 45 patients suffering from hearing loss only (hearing loss group) and 50 healthy subjects not suffering from tinnitus or hearing loss (control group); the age ranges from 20 to 60 years old. The studied sample was subjected to full ear, nose and throat examinations and audiological evaluation. Depression, Anxiety and Stress Scale (DASS) was developed by Levibond H and Levibond F to assess three self-report scales designed to measure the negative emotional status of depression, anxiety and stress. All patients and control group were evaluated by DASS. (1) Depression: males were affected more than females. All patients over 60 years were affected by depression. The duration of tinnitus seems correlating with the severity of depression. Only 2 patients (4.3 %) of the hearing loss group suffer from depression. (2) Anxiety: 90 % of males suffer from anxiety as compared to 83.3 % females. The age group 20-29 years old suffers more than other age groups. Only 4 patients (8.7 %) of hearing loss group suffer from anxiety. (3) Stress: females seem to be affected by the stress (76.7 %) more than males (67.5). Patients in age group 30-39 suffer the most from the disease. There is a direct correlation between duration of tinnitus and severity of stress. No one of the hearing loss group suffers from stress. In conclusion, depression, anxiety and stress should be taken into consideration in the treatment of patients suffering from tinnitus.
The majority of patients with post-mumps sensorineural hearing loss had peripheral vestibular pathology in the same ear as hearing loss. Further research should be directed to saving the inner ear following mumps infection.
Objective:-Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity can influence the whole body, including Ear, owing to mega inflammation.The primary target of this research is to detect minor changes in the hearing of obese children by Otoacoustic Emission (OAE) and High Frequency Audiometry (HFA). Patients and Method:-The current study is prospective that done at otorhinolaryngology clinic of Minia University Hospital, the study sample was divided into two subgroups, their age range from 6 to 17 years. The control group consisted of 20 children with average weight, while the experimental group consisted of 58 obese children. Both groups had no history of systemic or immunological diseases that affect their hearing. There were no history of hearing loss, delayed speech and language development or consanguinity . Both groups were subjected to Measurement of transient evoked otoacoustic emission, Distortion Product Otoacoustic Emission (OAE), and High-Frequency Audiometry (HFA)Results:-As regard of the audiological evaluation, there is no statistically significant difference between the two groups in the Pure Tone Audiometry (PTA) in all frequencies (from 0.25 to 8). HFA revealed a statistically significant difference (P < 0.05) between the two groups in 20000 HZ frequency.Transient OAE shows a statistically significant difference (P < 0.001) between both groups, while DPOAE shows no statistically significant difference between both groups as all ears were normal in the response.Conclusion:- Obesity is not a simple disease, but it impairs the high-frequency portion of the cochlea, early detection of any subtle affection of the cochlea must be detected, and screening of obese children is mandatory even if there is no complaint of hearing diminution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.